In a first-in-human study, researchers at The University of Texas MD Anderson Cancer Center observed strong responses and early signs of antitumor activity in patients with difficult-to-treat ...

Diffuse large B-cell lymphoma (DLBCL) is an aggressive and rapidly progressing form of lymph node cancer that affects around 6,000 people in Germany ...

A team led by UCL researchers with Great Ormond Street Hospital (GOSH) and Moorfields Eye Hospital, found B cells—alongside T cells—play a key role in arthritis-related eye disease (JIA uveitis), a ...

Dr. Sebastian Scheich of University Hospital Frankfurt will receive around €2 million over the next six years through the ...

Researchers at IIT Bombay have developed a simpler and more efficient method to recover immune cells grown in the lab for T-cell–based cancer therapies ...

Detailed price information for Biovaxys Technology Corp (BIOV-CN) from The Globe and Mail including charting and trades.

A surface capable of responding to chemical signals generated by microorganisms and automatically producing biocidal ...

Researchers at Texas A&M are pairing a widely used ingredient with advanced medical technology to develop new treatments for ...

Bone fractures usually heal efficiently, but in some patients this process fails, causing nonunion. A recent study identifies ...

An immunotherapy reduces plaque in the arteries of mice, offering a potential new strategy to treat cardiovascular disease, ...

Researchers have proposed a novel integrated framework to understand the complex progression of autoimmune skin diseases. A ...

A responsive silica nanocomposite generates biocidal oxygen species only when microbes alter local chemistry, allowing ...